- Cholinesterase inhibitors for Alzheimer's disease
- Cholinesterase inhibitors for delirium
- Cholinesterase inhibitors for dementia with Lewy bodies
- Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
- Cholinesterase inhibitors for Parkinson's disease dementia
- Citalopram versus other anti-depressive agents for depression
- Clonidine for smoking cessation
- Clotiapine for acute psychotic illnesses
- Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
- Clozapine versus other atypical antipsychotics for schizophrenia
- Clozapine versus typical neuroleptic medication for schizophrenia
- Cognition-based interventions for healthy older people and people with mild cognitive impairment
- Cognitive behaviour therapy for chronic fatigue syndrome in adults
- Cognitive behavioural interventions for sleep problems in adults aged 60+
- Cognitive behavioural therapy (CBT), third‐wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents
- Cognitive behavioural therapy for anxiety disorders in children and adolescents
- Cognitive behavioural therapy for men who physically abuse their female partner
- Cognitive behavioural therapy for tinnitus
- Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia
- Cognitive reframing for carers of people with dementia
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.